Charles Schwab Investment Management Inc I Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $160.0 $41,577 - $28.9 Million	180,772 New	180,772 $31,000
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $134,832 - $269,664	-586,227 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.3 - $0.61 $16,225 - $32,991	54,084 Added 10.16%	586,227 $252,000
Q2 2021 Aug 16, 2021	BUY	$1.22 - $1.65 $2,380 - $3,219	1,951 Added 0.37%	532,143 $804,000
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $95,093 - $211,140	80,588 Added 17.92%	530,192 $817,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $268,544 - $572,895	255,757 Added 131.94%	449,604 $473,000
Q3 2020 Nov 13, 2020	BUY	$1.7 - $6.41 $88,253 - $332,768	51,914 Added 36.58%	193,847 $394,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $2.46 $123,481 - $349,155	141,933 New	141,933 $316,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.